Tranexamic Acid (TXA) in Pediatric Cardiac Surgery

• Status: Completed
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine tranexamic acid plasma levels in children undergoing cardiac surgery at risk of bleeding and to compare two dosing regimens.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre Chirurgical Marie Lannelongue
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• children weighing between 10 and 30kg surgery with cardiopulmonary bypass for congenital heart disease deemed hemorrhagic

Exclusion Criteria:

• the patients undergoing a surgical procedure short and simple

• patients with past history of convulsions neurologiques especially allergies to the TA

• patients with renal insufficiency